Pages that link to "Q34626005"
Jump to navigation
Jump to search
The following pages link to Randomized comparative study of cefixime versus cephalexin in acute bacterial exacerbations of chronic bronchitis (Q34626005):
Displayed 20 items.
- Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response (Q24650974) (← links)
- Identification and characterization of outer membrane proteins G1a and G1b of Moraxella catarrhalis (Q30832563) (← links)
- PEPT1-mediated cefixime uptake into human intestinal epithelial cells is increased by Ca2+ channel blockers (Q33183596) (← links)
- Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview (Q33589242) (← links)
- Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review (Q33975684) (← links)
- Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis (Q34001748) (← links)
- Antigenic structure of outer membrane protein E of Moraxella catarrhalis and construction and characterization of mutants (Q34004983) (← links)
- Conservation of outer membrane protein E among strains of Moraxella catarrhalis (Q34007555) (← links)
- The Use of Oral Antibiotics in Daily Clinical Practice (Q36717724) (← links)
- COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA. (Q36860798) (← links)
- Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections. (Q40463584) (← links)
- Adverse effects of newer cephalosporins. An update (Q40858398) (← links)
- Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials (Q41129490) (← links)
- Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten (Q41132894) (← links)
- Antibacterial-induced hepatotoxicity. Incidence, prevention and management (Q41156683) (← links)
- Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model (Q41836038) (← links)
- Randomized comparison of once-daily ceftibuten and twice-daily clarithromycin in the treatment of acute exacerbation of chronic bronchitis (Q46419223) (← links)
- Acute exacerbations of chronic bronchitis. (Q50143256) (← links)
- Defining criteria for the pharmacoeconomic evaluation of new oral cephalosporins (Q74823748) (← links)
- Efficacy and Tolerability of 5- vs 10-Day Cefixime Therapy in Acute Exacerbations of Chronic Bronchitis (Q80967104) (← links)